EVOQ Remedies Ltd.
Snapshot View

14.32 -0.92 ▼-6.0%

24 May 2022, 04:01:00 PM
Volume: 16,000

Overview View Details

Sector Trading Compare with Sector peers
Industry Trading Compare with Industry peers
Website http://www.evoqremedies.com
Market Cap 19.48 Cr.
Enterprise Value(EV) 19.45 Cr. 2021-03
Financial Indicators
Earnings per share (EPS) 0.52 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) 27.28 Trailing Twelve Months Ending 2021-03
Industry PE 119.83 Trailing Twelve Months Ending 2021-03
Book Value / Share 16.74 Trailing Twelve Months Ending 2021-03
Price to Book Value 0.86 Calculated using Price: 14.32
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 1.36 Cr. 13,600,000 Shares
FaceValue 10
Company Profile

EVOQ Remedies is one of the recognized trading house of Pharmaceuticals Raw Materials, Excipients, Bulk Drugs at affordable price catering to the customers located in Ahmedabad. It procures the pharmaceuticals Raw Materials products and chemicals from the suppliers which are having WHO-GMP approved production facilities in India and by focusing on its first-class distribution expertise.

In the area of Pharmaceuticals Raw Materials, Excipients, Bulk Drugs etc., the company is specializes in offering quality products and affordable trading in Gujarat. The company has a team of focused industry experts, who have in-depth knowledge of the industry and have with them expertise in offering best solutions for meeting their specific needs. It procure all the products from certified & reliable Manufacturers & Importers, who follow procedures as per the stringent national and international quality and safety standards. In order to achieve the task, it keep its regular visit to ensure quality and reliability of the products. Keeping its basic objective in mind, it strive hard to exceed all the expectations of its clients by supplying best quality products at the most reasonable prices. EVOQ is having its registered office, corporate office and storage location facilities located in Ahmedabad. In the healthcare segment, EVOQ being into trading business offers a wide basket of products.

EVOQ majorly does trading in following segments of pharmaceuticals raw materials:

  • Excipients
  • Nutraceuticals
  • Pellets
  • Solvents
  • Sweetners
  • Vitamins
  • Amino Acids
  • Bulk Drugs
  • Dairy Products
  • Active Pharmaceuticals Ingredients

Business area of the company

The company specializes in offering quality Pharmaceuticals Raw Material products, Excipients, and Bulk Drugs at an affordable prices.

Major events:

  • 2010: Incorporation of Company as ‘Salus Life Science and Research Private Limited’ at Ahmedabad, Gujarat on February 24th, 2010 under the provisions of the Companies Act, 1956.
  • 2021: Conversion of the Company into public limited company, the name of the company was changed to ‘Evoq Remedies Limited’ and fresh Certificate of Incorporation dated July 28, 2021 was issued by Registrar of Companies, Ahmedabad.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
-6.04%
1 Week
-8.79%
1 Month
-13.47%
3 Month
6 Month
1 Year
2 Year
5 Year
10 Year
3 years 2019-03 2020-03 2021-03
Return on Equity (%) 49.78 1.34 188.09
Return on Capital Employed (%) 68.94 2.69 247.43
Return on Assets (%) 0.52 0.01 10.42

Balance Sheet View Details

Particulars 3 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Shh. Funds 0 0 1
Non Curr. Liab. 0 0
Curr. Liab. 2 6 7
Minority Int.
Equity & Liab. 2 6 8
Non Curr. Assets
Curr. Assets 2 6 8
Misc. Exp. not W/O
Total Assets 2 6 8

Profit Loss View Details

Particulars 3 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Net Sales 3 9 10
Other Income
Total Income 3 9 10
Total Expenditure -3 -9 -9
PBIDT 0 1
Interest
Depreciation
Taxation 0
Exceptional Items
PAT 0 1
Adjusted EPS

Cash Flow View Details

Particulars 3 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0
Cash Fr. Inv.
Cash Fr. Finan.
Net Change 0 0 0
Cash & Cash Eqvt 0 0

Shareholding Pattern View Details

1 Qtrs 2022-03 (%)
Promoter 73.53
Public 26.47
Depository Receipts 0.00
Promoter Holding Pledge (%) 0.00

Announcements View Details

Mon, 23 May 2022
Board Meeting Intimation for The Audited Financial Results Of The Company For The Quarter And Year Ended On 31St March 2022 Along With Auditor'S Report.
Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 inter alia to consider and approve the Audited Financial Results of the Company for the Quarter and Year ended on 31st March 2022 along with Auditors Report.
Sat, 30 Apr 2022
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1Name of CompayEvoq Remedies Ltd
2CINU24230GJ2010PLC059692
3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) 10.19
4Highest Credit Rating during the previous FY NA
4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable
5Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the frameworkBSE


We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No



Name of the Company Secretary: TEJ BHARATKUMAR HANJ
Designation: Company Secretary
EmailId: cs@evoqremedies.com
Name of the Chief Financial Officer: YOGESH RAJPUT
Designation: Chief Financial Officer
EmailId: cs@evoqremedies.com

Date: 30/04/2022

Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
Sat, 30 Apr 2022
Submission Of Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Financial Year Ended On 31St March 2022
With reference to the captioned subject kindly find attached herewith Certificate issued under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 for the financial year ended on 31st March 2022. Kindly take the same on your record and oblige us.Thanking You

Technical Scans View Details

Tue, 24 May 2022
High Delivery Percentage High Delivery Percentage
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
High Decrease 1 Month High Decrease 1 Month
Close Crossing 20 EMA From Above Close Crossing 20 EMA From Above
Mon, 23 May 2022
Opening at Low Opening at Low

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. 246,126.24 2,159.00 -0.5%
Redington (India) Ltd. 10,846.62 138.80 -3.0%
MMTC Ltd. 5,977.50 39.85 -1.2%
Optiemus Infracom Ltd. 2,499.77 291.30 -3.7%
Polo Queen Industrial & Fintech Ltd. 1,823.12 54.30 -5.0%
SIRCA Paints India Ltd. 1,186.34 432.90 -3.8%
Shree Global Tradefin Ltd. 994.80 7.82 -2.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2022-03 316.94 2,159.00 -0.5%
Redington (India) Ltd. Consolidated 2022-03 8.47 138.80 -3.0%
MMTC Ltd. Consolidated 2021-12 0.00 39.85 -1.2%
Optiemus Infracom Ltd. Consolidated 2021-12 25.20 291.30 -3.7%
Polo Queen Industrial & Fintech Ltd. Consolidated 2021-12 0.00 54.30 -5.0%
SIRCA Paints India Ltd. Consolidated 2021-12 32.28 432.90 -3.8%
Shree Global Tradefin Ltd. Consolidated 2021-12 0.00 7.82 -2.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2022-03 8.22 2,159.00 -0.5%
Redington (India) Ltd. Consolidated 2022-03 1.87 138.80 -3.0%
MMTC Ltd. Consolidated 2021-12 -20.85 39.85 -1.2%
Optiemus Infracom Ltd. Consolidated 2021-12 7.65 291.30 -3.7%
Polo Queen Industrial & Fintech Ltd. Consolidated 2021-12 11.34 54.30 -5.0%
SIRCA Paints India Ltd. Consolidated 2021-12 5.32 432.90 -3.8%
Shree Global Tradefin Ltd. Consolidated 2021-12 1.55 7.82 -2.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 0.93 2,159.00 -0.5%
Redington (India) Ltd. Consolidated 2021-03 0.09 138.80 -3.0%
MMTC Ltd. Consolidated 2021-03 24.24 39.85 -1.2%
Optiemus Infracom Ltd. Consolidated 2021-03 0.31 291.30 -3.7%
Polo Queen Industrial & Fintech Ltd. Consolidated 2021-03 0.10 54.30 -5.0%
SIRCA Paints India Ltd. Consolidated 2021-03 0.07 432.90 -3.8%
Shree Global Tradefin Ltd. Consolidated 2021-03 0.01 7.82 -2.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 4.38 2,159.00 -0.5%
Redington (India) Ltd. Consolidated 2021-03 17.02 138.80 -3.0%
MMTC Ltd. Consolidated 2021-03 -160.71 39.85 -1.2%
Optiemus Infracom Ltd. Consolidated 2021-03 30.53 291.30 -3.7%
Polo Queen Industrial & Fintech Ltd. Consolidated 2021-03 0.21 54.30 -5.0%
SIRCA Paints India Ltd. Consolidated 2021-03 8.59 432.90 -3.8%
Shree Global Tradefin Ltd. Consolidated 2021-03 -0.07 7.82 -2.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 4.38 2,159.00 -0.5%
Redington (India) Ltd. Consolidated 2021-03 17.02 138.80 -3.0%
MMTC Ltd. Consolidated 2021-03 -160.71 39.85 -1.2%
Optiemus Infracom Ltd. Consolidated 2021-03 30.53 291.30 -3.7%
Polo Queen Industrial & Fintech Ltd. Consolidated 2021-03 0.21 54.30 -5.0%
SIRCA Paints India Ltd. Consolidated 2021-03 8.59 432.90 -3.8%
Shree Global Tradefin Ltd. Consolidated 2021-03 -0.07 7.82 -2.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 39,537.13 2,159.00 -0.5%
Redington (India) Ltd. Consolidated 2021-03 56,945.86 138.80 -3.0%
MMTC Ltd. Consolidated 2021-03 30,001.47 39.85 -1.2%
Optiemus Infracom Ltd. Consolidated 2021-03 314.39 291.30 -3.7%
Polo Queen Industrial & Fintech Ltd. Consolidated 2021-03 32.11 54.30 -5.0%
SIRCA Paints India Ltd. Consolidated 2021-03 143.18 432.90 -3.8%
Shree Global Tradefin Ltd. Consolidated 2021-03 0.80 7.82 -2.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 746.32 2,159.00 -0.5%
Redington (India) Ltd. Consolidated 2021-03 786.61 138.80 -3.0%
MMTC Ltd. Consolidated 2021-03 -790.07 39.85 -1.2%
Optiemus Infracom Ltd. Consolidated 2021-03 86.50 291.30 -3.7%
Polo Queen Industrial & Fintech Ltd. Consolidated 2021-03 0.33 54.30 -5.0%
SIRCA Paints India Ltd. Consolidated 2021-03 16.58 432.90 -3.8%
Shree Global Tradefin Ltd. Consolidated 2021-03 -0.24 7.82 -2.9%